CClinicalTrials.gg
CompletedNCT05714384Updated May 26, 2026

Calcium Silicate Sealer-based Obturation in Root Canal Retreatment

An observational study in Root Canal Infection and Periapical Diseases, sponsored by Ministry of Health, Kuwait. Completed at 1 site in Kuwait. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-26.

Sponsored by Ministry of Health, Kuwait · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
136
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study will evaluate the outcome of calcium silicate sealer-based obturations in root canal retreatment.

Read the detailed description

Calcium silicate sealer-based obturations have shown promising performance in primary root canal treatments, but there is a lack of prospective studies evaluating their effectiveness in secondary root canal treatments, which often involve more persistent microbial challenges. The aim of this study is to assess the clinical and radiographic outcomes of calcium silicate sealer-based obturations in root canal retreatment and to identify potential prognostic factors for healing.

Objectives:

  1. To determine the success rate of calcium silicate sealer-based obturations in root canal retreatment.
  2. To compare the observed outcomes with previously published retreatment studies using conventional obturation techniques.
  3. To identify potential prognostic factors associated with favourable or unfavourable outcomes.

This will be a prospective cohort study conducted at Jaber Al-Ahmed Dental Center. Informed written consent will be obtained from all participants. All nonsurgical root canal retreatments will be performed by a specialist endodontist using a calcium silicate-based sealer (CeraSeal, Meta Biomed) following current evidence-based standards. Treatments will be recorded in a secure database, and all cases will be followed for a minimum of 12 months.

Clinical and radiographic records will be reviewed, and eligibility will be determined according to predefined inclusion and exclusion criteria. All patient data will be anonymized before extraction and analysis.

The primary outcome at 12 months will be the proportion of teeth classified as having a favourable outcome. This outcome will serve as the dependent variable in logistic regression models evaluating the associations between healing and potential predictors, including age, sex, tooth type, periapical status, preoperative pain, quality of the previous root filling, sinus tracts, apical patency, final apical preparation size, and sealer extrusion. Separate univariable logistic regression models will be performed for each predictor. A multivariable logistic regression model will then be constructed to evaluate the combined effects of independent variables, with exploratory assessment of two-way interactions.

This study was designed as a single-arm prospective outcome investigation with the primary endpoint being the proportion of teeth exhibiting a favourable outcome. A precision-based approach was used to determine the required sample size. An anticipated healing rate of 80 percent was assumed based on systematic reviews and prospective cohort studies that report healing rates between 77 and 87 percent for nonsurgical retreatment.

Using PASS (version 25.0.3; NCSS, LLC, Kaysville, Utah, USA) with the One Proportion - Confidence Interval procedure (two-sided 95 percent confidence level, Wilson method), a sample size of 95 teeth was required to estimate the healing proportion with a target precision of approximately ±8 percentage points. Allowing for up to 30 percent attrition, the planned enrolment was set at 136 teeth, which is expected to yield at least 95 evaluable cases. This target aligns with sample sizes used in previous prospective clinical studies on endodontically retreated teeth.

02

Conditions studied

  • Root Canal Infection
  • Periapical Diseases

Browse trials for

03

In context

Periapical Diseases

44 studies on the registry are indexed under Periapical Diseases; 12 are open to participants now.

Browse Periapical Diseases studies →

Lead sponsor

Ministry of Health, Kuwait is the lead sponsor of 14 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients who present with symptomatic teeth and require root canal retreatment will be assessed based on inclusion and exclusion criteria.

Inclusion criteria

  • Participants must be 18-65 years of age at the time of recruitment
  • Participants must have a classification of I or II on the American Society of Anesthesiologists (ASA) physical status classification system
  • Participants must not have known allergies to any materials used in the study
  • Participants must agree to participate in the study by signing a consent form
  • Participants must have good oral hygiene
  • All types of permanent teeth that require root canal retreatment are included (incisors, canines, premolars \& molars)
  • The teeth must be restorable and have fully formed roots with no advanced periodontal disease

Exclusion criteria

Exclusion Criteria:

  • ASA classification of III or more
  • Pregnant or breastfeeding women
  • Patients who are unable to give consent
  • Patients who have advanced periodontal disease or teeth with more than 5mm probing
  • Teeth with incomplete root formation
  • Teeth that have a poor restorative prognosis
  • Teeth presenting with signs of a vertical root fracture
  • Teeth with blocked or non-negotiable canals
  • Teeth with broken instruments
  • Teeth with iatrogenic perforations
  • Teeth requiring posts or extensive prosthetic rehabilitation
  • Teeth with cracks
  • Teeth with internal or external root resorption
  • Teeth with uncontrollable exudate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
136 participants (actual)
Patient registry
No

Interventions

  • DeviceCeraSeal (Calcium Silicate-based Root Canal Sealer)

    A calcium silicate-based root canal sealer will be used in cases requiring root canal retreatment.

06

What researchers measure

Primary outcomes

  1. Assessment of radiographic healing with cone beam computed tomography (CBCT) scans using Estrela's PAI (periapical index)

    Estrela's PAI based on CBCT will be used in logistic regression models with different predictor variables.

    Time frame: Comparison of periapical lesion size at baseline and 12 months

  2. Assessment of clinical outcome by assessing the resolution/persistence/development of clinical signs and symptoms

    The examiner will label the teeth as having a normal clinical outcome (absence of pain, swelling and other symptoms, no sinus tract, no loss of function) or showing signs and symptoms clinical outcome (the tooth is associated with signs and/or symptoms of infection).

    Time frame: Comparison at baseline and 12 months

07

Study locations

1 site
  • Jaber Al-Ahmed Dental Center
    Janūb as Surrah, Hawalli Governate 00000, Kuwait
08

References and documents

Individual participant data

Plan to share: No — IPD will not be available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05714384
Lead sponsor
Ministry of Health, Kuwait
Collaborators
Kuwait Institute for Medical Specialization
Responsible party
Ahmed Aldowaisan (Principal Investigator, Specialist in Endodontics, Ministry of Health, Kuwait) — Principal investigator
First posted
Feb 6, 2023
Start date
Mar 5, 2023
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
May 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion